essential hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Males or non-pregnant females aged 18 to 80 years (2) Meet the diagnostic criteria for hypertension in the Chinese Guidelines for the Prevention and Treatment of Hypertension 2018 Revised Edition (3) Subjects are able to understand the purpose of the clinical trial, voluntarily participate and sign the informed consent form
Exclusion criteria
Exclusion criteria: (1) Serious adverse reactions to drug therapy (2)Those who are ineffective in drug therapy (3)Patients with secondary hypertension (4)Patients with intractable hypertension (5)Those who are unable to complete the prescribed exercise program (6) Patients with other malignant diseases affecting participation in the study (7) Patients who, in the judgment of the investigator, have poor compliance and are unable to complete the clinical trial as required
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microcirculation;Hemorheology; | — |
Secondary
| Measure | Time frame |
|---|---|
| Autonomic neurotransmitters and corresponding receptors;Inflammatory indicators;RAAS system indicators;Vascular endothelial function indicators;Quality of Life Scale;Anxiety Depression Inventory;Stress Perception Scale;Heart rate variability;Sleep Scale;Variability of blood pressure;Calcium ion and its regulatory proteins; | — |
Countries
China
Contacts
Beijing Normal University